Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort
Re-irradiation has been shown to be a valid option with proven efficacy for recurrent high-grade glioma patients. Overall, up to now it is unclear which patients might be optimal candidates for a second course of irradiation. A recently reported prognostic score developed by Combs et al. may guide t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 June 2014
|
| In: |
Radiation oncology
Year: 2014, Volume: 9, Pages: 1-6 |
| ISSN: | 1748-717X |
| DOI: | 10.1186/1748-717X-9-128 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1748-717X-9-128
|
| Author Notes: | Maximilian Niyazi, Maya Flieger, Ute Ganswindt, Stephanie E. Combs and Claus Belka |
| Summary: | Re-irradiation has been shown to be a valid option with proven efficacy for recurrent high-grade glioma patients. Overall, up to now it is unclear which patients might be optimal candidates for a second course of irradiation. A recently reported prognostic score developed by Combs et al. may guide treatment decisions and thus, our mono-institutional cohort served as validation set to test its relevance for clinical practice. |
|---|---|
| Item Description: | Gesehen am 12.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1748-717X |
| DOI: | 10.1186/1748-717X-9-128 |